$31.20
0.03% day before yesterday
Nasdaq, Nov 07, 10:00 pm CET
ISIN
US0453961080
Symbol
ASMB

Assembly Biosciences, Inc. Stock price

$31.20
+7.34 30.76% 1M
+18.79 151.41% 6M
+15.42 97.72% YTD
+13.70 78.29% 1Y
+13.44 75.68% 3Y
-35.64 53.32% 5Y
-80.52 72.07% 10Y
-346.80 91.75% 20Y
Nasdaq, Closing price Fri, Nov 07 2025
-0.01 0.03%
ISIN
US0453961080
Symbol
ASMB
Industry

Key metrics

Basic
Market capitalization
$485.5m
Enterprise Value
$410.5m
Net debt
positive
Cash
$75.0m
Shares outstanding
7.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
14.6 | 14.9
EV/Sales
12.4 | 12.6
EV/FCF
negative
P/B
26.8
Financial Health
Equity Ratio
28.0%
Return on Equity
-120.4%
ROCE
-130.0%
ROIC
121.1%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$33.3m | $32.6m
EBITDA
$-43.4m | $-44.0m
EBIT
$-43.5m | $-43.7m
Net Income
$-39.0m | $-30.4m
Free Cash Flow
$-55.9m
Growth (TTM | estimate)
Revenue
54.8% | 14.3%
EBITDA
13.7% | 2.9%
EBIT
13.9% | 3.8%
Net Income
14.6% | 24.3%
Free Cash Flow
-331.7%
Margin (TTM | estimate)
Gross
-
EBITDA
-130.5% | -134.9%
EBIT
-130.9%
Net
-117.2% | -93.3%
Free Cash Flow
-168.0%
More
EPS
$-5.1
FCF per Share
$-7.3
Short interest
11.6%
Employees
73
Rev per Employee
$390.0k
Show more

Is Assembly Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Assembly Biosciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Assembly Biosciences, Inc. forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a Assembly Biosciences, Inc. forecast:

Buy
91%
Hold
9%

Financial data from Assembly Biosciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
33 33
55% 55%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 18 18
18% 18%
54%
- Research and Development Expense 59 59
18% 18%
177%
-43 -43
14% 14%
-130%
- Depreciation and Amortization 0.13 0.13
50% 50%
0%
EBIT (Operating Income) EBIT -44 -44
14% 14%
-131%
Net Profit -39 -39
15% 15%
-117%

In millions USD.

Don't miss a Thing! We will send you all news about Assembly Biosciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Assembly Biosciences, Inc. Stock News

Neutral
GlobeNewsWire
2 days ago
– Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking poster presentation – SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced Phase 1b clini...
Neutral
GlobeNewsWire
26 days ago
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the company will participate in fireside chats at two upcoming investor conferences.
Neutral
GlobeNewsWire
30 days ago
– Late-breaking oral presentation highlights interim Phase 1b data reported earlier this year for two cohorts in participants with recurrent genital herpes –  – Statistically significant reductions in HSV-2 shedding rate, high viral load shedding rate and genital lesion rate observed in the cohort evaluating 350 mg weekly oral dose compared to placebo – – Interim data evaluating a monthly dosin...
More Assembly Biosciences, Inc. News

Company Profile

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.

Head office United States
CEO Jason Okazaki
Employees 73
Founded 2005
Website www.assemblybio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today